Fletcher v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
| Barry Fletcher |
| Chattem, Inc., GlaxoSmithKline LLC, Sanofi US Services Inc., Pfizer Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. |
| 0:2020cv60488 |
| March 5, 2020 |
| U.S. District Court for the Southern District of Florida |
| Personal Inj. Prod. Liability |
| 28 U.S.C. ยง 1332 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 6, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 1 Clerks Notice to Filer re: Electronic Case. Case administratively closed - No Initiating Document filed/attached. No further entries will be made on this case. (bb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
